SCHEMBL1385155

SCHEMBL1385155

CCOC(=O)Nc1ccc(C(=O)/C=C/c2cc(N3CCOCC3)c3ccccc3n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
RAB9A P51151 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
MOK Q9UQ07 2/20 0.51
NCF1 P14598 1/20 0.45
MTOR P42345 4/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 1/20 0.45
HIF1A Q16665 1/20 0.45
PIK3CA P42336 3/20 0.43
PIK3R1 P27986 2/20 0.43
GAA P10253 1/20 0.43
METAP1 P53582 1/20 0.43
MAPK1 P28482 1/20 0.43
POLB P06746 1/20 0.43
HTR1A P08908 1/20 0.43
HTR1D P28221 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1385160 1.00 MAPT (0.53) MAPTRAB9ANPSR1MOKNCF1
SCHEMBL1385466 0.92 RAB9A (0.55) MAPTRAB9ANPSR1MOKNCF1
SCHEMBL5101856 0.92 RAB9A (0.55) MAPTRAB9ANPSR1MOKNCF1
SCHEMBL1386142 0.91 MOK (0.54) MAPTRAB9AMOKNCF1MTOR
SCHEMBL1386140 0.91 MOK (0.54) MAPTRAB9AMOKNCF1MTOR
SCHEMBL1384275 0.91 MOK (0.49) MAPTRAB9ANPSR1MOKNCF1
SCHEMBL1384278 0.91 MOK (0.49) MAPTRAB9ANPSR1MOKNCF1
SCHEMBL1383862 0.91 MTOR (0.53) MAPTRAB9ANPSR1MOKMTOR
SCHEMBL1383863 0.91 MTOR (0.53) MAPTRAB9ANPSR1MOKMTOR
SCHEMBL1385200 0.90 MOK (0.55) MAPTRAB9ANPSR1MOKNCF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4790704-B2 2011-10-12 JP claimed
US-20080207608-A1 2-Propene-1-Ones As Hsp 70 Inducers TORRENT PHARMACEUTICALS LTD. (IN) 2008-08-28 US claimed
EP-1748987-A2 2-PROPENE-1-ONES AS HSP 70 INDUCERS Torrent Pharmaceuticals Ltd (IN) 2007-02-07 EP claimed
WO-2005097746-A2 2-PROPENE-1-ONES AS HSP 70 INDUCERS TORRENT PHARMACEUTICALS LTD (IN) 2005-10-20 WO claimed
US-20080207608-A1 2-Propene-1-Ones As Hsp 70 Inducers TORRENT PHARMACEUTICALS LTD. (IN) 2008-08-28 US disclosed
EP-1748987-A2 2-PROPENE-1-ONES AS HSP 70 INDUCERS Torrent Pharmaceuticals Ltd (IN) 2007-02-07 EP disclosed
WO-2005097746-A2 2-PROPENE-1-ONES AS HSP 70 INDUCERS TORRENT PHARMACEUTICALS LTD (IN) 2005-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207608-A1 2-Propene-1-Ones As Hsp 70 Inducers HSPB1, HSF1, HSPE1 MAPT 71/4885RAB9A 1703/4885NPSR1 2930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.